Cardinal Health Inc. is recalling 48 boxes of Tremfya (guselkumab) Injection, 100 mg/mL, because the medication may have been exposed to improper temperatures during storage or distribution. Tremfya is a prescription injection used to treat certain inflammatory conditions, and maintaining the correct temperature is critical for the drug's safety and effectiveness. These products were distributed in Alabama, Louisiana, Mississippi, and Tennessee. If you have this medication, you should contact your healthcare provider or pharmacist immediately to determine if your specific supply is safe to use.
Exposure to temperatures outside of the manufacturer's required range, known as temperature abuse, can cause the medication to break down or lose its effectiveness. This may result in the patient receiving a less potent dose than intended, which could lead to inadequate treatment of their medical condition.
Healthcare consultation and refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.